RJA
ORIC icon

Raymond James & Associates’s Oric Pharmaceuticals ORIC Stock Holding History

Raymond James & Associates’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,816
Closed -$412K – 4165
2021
Q1 		$412K Sell
16,816
-10,025
-37% -$317K ﹤0.01% 3151
2020
Q4 		$909K Sell
26,841
-9,385
-26% -$269K ﹤0.01% 2413
2020
Q3 		$906K Buy
36,226
+5,941
+20% +$141K ﹤0.01% 2230
2020
Q2 		$1.02M Buy
+30,285
New +$967K ﹤0.01% 2148

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return